Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

November 26, 2010

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

November 23, 2010

High alpha-carotene levels linked to longer life: Study
High blood levels of the carotenoid alpha-carotene may reduce the risk of dying from cardiovascular disease (CVD), cancer, and all other causes by up to 39 percent, suggest results from a 14 year study.
Read article at nutraingredients-usa.com
Comment: To read the abstract for this study, click here.

November 20, 2010

Study Sees Link Between Low Salt Levels, Fracture Risk in Older Adults
New research links lower-than-normal levels of sodium (salt) in the blood to a higher risk of broken bones and falls in older adults. Even mildly decreased levels of sodium can cause problems, the researchers contend. "Screening for a low sodium concentration in the blood, and treating it when present, may be a new strategy to prevent fractures," study co-author Dr. Ewout J. Hoorn, of Erasmus Medical Center in Rotterdam, the Netherlands, said in a news release from the American Society of Nephrology.
Read article at health.usnews.com
Comment: Research has shown that 20% of patients taking diuretics, a class of drugs commonly prescribed for high blood pressure or heart conditions, end up with reduced sodium and potassium levels. Despite this, however, evidence suggests that perhaps as few as a third of patients on these drugs have their levels of these minerals tested – despite the fact that reduced levels are well known to lead to a wide range of health problems. To learn how high blood pressure can be eradicated naturally, without the use of diuretics, click here.

November 19, 2010

Antioxidants may reduce inflammatory effects of Alzheimer’s: Study
Consuming an antioxidant-rich beverage may reduce levels of the amino acid homocysteine, and counter the detrimental inflammatory effects associated with Alzheimer’s disease, suggests a new study. Daily consumption of the antioxidant-rich drink for eight months was associated with a smaller increase in homocysteine levels, compared with the placebo group, and the effects were even more significant in people with moderate Alzeimer’s disease, according to findings published in the Journal of the Neurological Sciences.
Read article at nutraingredients.org

November 19, 2010

Eating a variety of fruit cuts lung cancer risk
Eating five portions of fruit and vegetables per day is one of the means that experts most frequently recommend for preventing cancer. Now, the European EPIC study carried out by researchers from 10 countries has shown that, in the case of lung cancer, the important thing is not just the quantity but also the variety of fruit consumed, which can reduce the risk by up to 23%.
Read article at physorg.com

November 19, 2010

Pomegranate juice may reduce kidney dialysis complications: Study
Pomegranate juice may reduce complications in kidney disease patients on dialysis, including the high morbidity rate due to infections and cardiovascular events, according to a preliminary study. The study suggests that 12 months consumption of pomegranate juice “has a continuous, accumulative, beneficial effect for dialysis patients.” The researchers found that pomegranate juice consumption yields a lower level of oxidative stress, reduced inflammation, an improvement in lipid profile, and reductions in blood pressure.
Read article at nutraingredients.org

November 17, 2010

Aged garlic shows blood pressure improvement benefits: Study
Daily supplements of an aged garlic extract may reduce systolic blood pressure by 10.2 mmHg, suggests new data from Australia.
Read article at nutraingredients.com

For more natural health news, click here.

See also our 2001-2009 news archive, by clicking here.

Pharma "Business with Disease" News

November 23, 2010

$12.6M awarded in drug case
Bone drug caused woman's jaw to disintegrate, jury says
A Mount Pleasant lawyer won $12.6 million in damages for the estate of a North Carolina woman whose jaws disintegrated while taking a bone-strengthening drug -- a side effect its manufacturer hid from consumers to protect sales, a jury ruled in federal court Monday. At least two similar cases involving the drugs Aredia and Zometa, manufactured by Switzerland-based pharmaceutical giant Novartis, are expected to be tried in South Carolina by the end of next year, attorney Vernon Glenn said. Clients from the Upstate and Midlands who have taken the drug also have suffered broken jawbones, he said. Hundreds of similar cases have been filed nationwide, he said.
Read article in The Post and Courier (USA)

November 19, 2010

Drugmaker pulls painkillers from US market over heart risks
Drugmaker Xanodyne Pharmaceuticals Inc. agreed Friday to pull two of its painkillers, Darvon and Darvocet, from the US market over heart risk concerns, the US Food and Drug Administration said. Similar withdrawals from the market of the drug also known as propoxyphene were recommended in Europe in 2009 and are already under way. "The FDA sought market withdrawal of propoxyphene after receiving new clinical data showing that the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities," the agency said.
Read article at physorg.com

November 19, 2010

Heart drug raises questions
Report links Multaq with 387 reports of adverse effects
A heart drug that was the subject of a Journal Sentinel investigative report earlier this year has been linked to an increasing number of adverse side effects, according to an analysis by a watchdog group that monitors medication errors and drug use in the U.S. The drug Multaq, or dronedarone, was associated with cases of heart failure, lethal irregular heart beats, problematic interactions with other drugs and impaired kidney function in a report released earlier this month by the Institute for Safe Medication Practices. "We have seldom seen a drug with so many issues in so many areas of its safety profile," the report said. Since the drug was approved by the U.S. Food and Drug Administration in 2009, Multaq has been linked to 387 reports of adverse events, including 24 deaths, the report said.
Read article in the Milwaukee-Wisconsin Journal Sentinel (USA)

November 17, 2010

Bid to ban export of 'execution' drug
An attempt will be made at the High Court today to prevent a British company exporting a drug which could be used in the execution of US prisoners. Solicitors representing two clients on Death Row and human rights group Reprieve are challenging Business Secretary Vince Cable's refusal to ban the overseas sale of sodium thiopental. The strong painkiller is given as the first of a cocktail of three drugs used in US state lethal injections. London-based solicitors firm Leigh Day & Co, acting for prisoners Edmund Zagorski and Ralph Baze, argue that Mr Cable's refusal was wrong in law. Leigh Day says the case arises from the state execution in Arizona of Jeffrey Landrigan on October 25.
Read article in The Independent (UK)
Comment: Archimedes Pharma, a British pharmaceutical company, is suspected to be the source of the sodium thiopental used in the execution of death-row prisoners in the US. Despite being fully aware of this, Vince Cable, the UK government’s Business Secretary, has steadfastly refused to use his powers under the UK’s Export Control Act to place an immediate ban on it being sold to the US for use in executions. As such, with the pharmaceutical industry already having been proven to have supplied the chemicals that killed tens of thousands of prisoners at the Auschwitz WWII concentration camp, some might argue that these and other possible links between the modern-day industry and executions are anything but surprising.

November 16, 2010

U.S. Scientists Commit Most Research Fraud: Study
A new study finds that nearly 800 research papers were retracted by medical journals for serious errors or faked data over the past decade, many of them authored by U.S. researchers.
Read article at medicinenet.com

October 21, 2010

Glaxo Receives Federal Subpoena About Avandia
The ongoing controversy over the Avandia diabetes pill - specifically, whether GlaxoSmithKline properly disclosed clinical trial data and its related marketing efforts - has prompted the US Department of Justice to issue a subpoena to the drugmaker. At the same time, several state attorneys general offices have issued Civil Investigative Demands.
Read article at pharmalot.com

October 20, 2010

Docs Should Avoid Company Info: Study
Does information provided by drugmakers to doctors result in higher prescribing frequency, higher costs and lower prescribing quality? This is not a new issue, of course, but a new study that attempted to quantify patterns says the answer is yes. And the researchers came to this conclusion by scouring 58 studies in several countires that examined a variety of company contact. This included visits by sales reps, journal advertisements, attendance at pharmaceutical sponsored meetings, information that was mailed to docs, prescribing software, and participation in sponsored clinical trials. The outcomes measured were quality, quantity, and cost of physician prescribing, according to the new study published in PLoS Medicine. The bottom line: the researchers found that docs who accepted meetings, briefings or other info from drugmakers were more likely to prescribe those products.
Read article at pharmalot.com

For more pharma "business with disease" news, click here.

See also our 2001-2009 news archive, by clicking here.

GMO News

November 16, 2010

Consumers reject GM food
EU Consumers are still overwhelmingly opposed to GM food, new research published by the European Commission shows. In a Europe-wide survey, 61 per cent of respondents said the development of GM food should not be encouraged, while only 23 per cent supported for the technology. The survey reveals an ‘overall suspicion of GM foods amongst the European public’ and showed that EU citizens do not see benefits of it and consider it to be ‘probably unsafe or even harmful’. They doubt its economic benefits and believe GM food harms the environment.
Read article at farmersguardian.com

November 12, 2010

Pressure for more retailers to use ‘reared without GM’ labels
European supermarkets are coming under NGO pressure to label produce from animals reared on non-GMO feed, following a move from Carrefour.
Read article at foodnavigator.com

For more GMO news, click here.

See also our 2001-2009 news archive, by clicking here.

Other Health-related News

November 23, 2010

The War for Nutrition Science Integrity
One nutrition organization looks to be in the pocket of Big Pharma and the worst of the junk food manufacturers. Another organization has been a more independent voice for nutrition. Guess which one is attempting to swallow the other? The American Society for Nutrition (ASN), the largest society for nutrition researchers in the US, openly receives support from pharmaceutical companies like Abbott Nutrition and Martek Biosciences, genetic engineering and pesticide giant Monstanto, food processor ConAgra, and junk food suppliers and producers Coca-Cola, Mars, Kraft, McDonald’s, General Mills, and Kellogg’s, not to mention the Sugar Association, Inc. (among many others). Think about that: an organization claiming “excellence in nutrition research and practice” receives major funding from companies making drugs, pesticides, and some of the most health-damaging foods on the planet. It must be greatly influenced by those companies’ worldviews.
Read article on the website of the Alliance for Natural Health (USA)

November 11, 2010

Stepping over stray dogs
But watch out for the Codex mess
At last year’s CCNFSDU meeting in Germany, the National Health Federation (with help from the Indian and Iraqi delegations) was able to stop the advance of those Guidelines on Nutrient Reference Values (NRVs) that would have set low numerical values for vitamins and minerals. Some delegations, especially Australia, were strongly pushing for these “dumbed down” NRVs to go forward. Had they gone forward at that time – as they very nearly did – then we would now be looking at well-advanced Codex NRVs of, for example, 45 milligrams for Vitamin C and 200 IUs for Vitamin D as providing 100% of an adult’s daily nutritional needs. This week of November 1-5, 2010, the CCNFSDU met once again to debate this and other NRV texts.
Read article on the website of the National Health Federation (USA)
Comment: To download our PowerPoint presentation explaining how Codex is increasingly being used as a vehicle for shaping global food and nutrient regulations to reflect draconian Brussels EU laws, click here.

For more health-related news, click here.

See also our 2001-2009 news archive, by clicking here.

Political News

November 19, 2010

Europe’s Dirty Secret: Financial Elite Looting Public Treasuries
In a revealing admission concerning the relationship between capitalist governments and international financial interests, the Financial Times on Tuesday wrote of “Europe’s dirty secret.” The newspaper editorialized against the plan of the European Union, the European Central Bank (ECB) and the International Monetary Fund to loan Ireland tens of billions of euros in order to guarantee in full the investments of international bankers and bondholders in the country’s failing banking system. Under the plan, Ireland will effectively surrender sovereignty over its economic policy to the EU and the IMF and agree to claw back the latest bailout of the global financial elite by imposing a new and even more savage round of attacks on the wages and living standards of the working class.
Read article on the Centre for Research on Globalization website

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

 

Back to the Newsletter Archive…